Business Description
NewAmsterdam Pharma is a Netherlands-based drug development company focused on treating heart and metabolic conditions. Its lead medicine, Obicetrapib, is a low-dose oral pill designed to reduce harmful cholesterol levels, currently being tested in multiple clinical trials both on its own and alongside another cholesterol-lowering drug. The company is also exploring whether Obicetrapib may offer benefits for patients with Alzheimer's disease.
